Literature DB >> 8112894

The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats.

P J Kuppen1, P H Basse, R H Goldfarb, C J Van De Velde, G J Fleuren, A M Eggermont.   

Abstract

The number of IL-2-activated natural killer (A-NK) cells reaching the tumor site in vivo may be crucial for their anti-tumor effect following adoptive immunotherapy. We investigated in a syngeneic rat model the infiltration of established lung metastases by adoptively transferred A-NK cells. The Wag rat colon carcinoma CC531 was injected via a tail vein to induce pulmonary metastases. Syngeneic A-NK cells were labeled with the fluorescent dye rhodamine (TRITC) and next injected via a tail vein in rats bearing day-12 lung tumors. The number of A-NK cells in tumor and in normal tissue per rat was counted in sections after administration of A-NK cells. At all time points tested, a significant linear relationship between the cross-section area of the tumor and the number of infiltrating cells was observed, but small tumor areas became fully infiltrated earlier than larger areas. At 24 hr after injection, approximately 10% of the injected cells were found in the tumor tissue and the average A-NK-cell-to-tumor-cell ratio was estimated to be 1:3. A-NK cells were found in the liver too, although the number of cells per mm2 tissue was low compared with the pulmonary tumor tissue. Very low numbers of A-NK cells were found in kidney, adrenal gland, spleen, and blood. We conclude that, in this syngeneic rat model, adoptively transferred A-NK cells are able to find and specifically infiltrate pulmonary metastases in a time-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112894     DOI: 10.1002/ijc.2910560418

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma.

Authors:  M Hagenaars; R Koelemij; N G Ensink; J D van Eendenburg; R L van Vlierberghe; A M Eggermont; C J van de Velde; G J Fleuren; P J Kuppen
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy?

Authors:  M Hagenaars; N G Ensink; P H Basse; M Hokland; U Nannmark; A M Eggermont; C J van de Velde; G J Fleuren; P J Kuppen
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Immune response, depression and fatigue in relation to support intervention in mammary cancer patients.

Authors:  Christina Lindemalm; Fariba Mozaffari; Aniruddha Choudhury; Helena Granstam-Björneklett; Mats Lekander; Bo Nilsson; Marja-Leena Ojutkangas; Anders Osterborg; Leif Bergkvist; Håkan Mellstedt
Journal:  Support Care Cancer       Date:  2007-06-12       Impact factor: 3.603

4.  Rat colon carcinoma cells that survived systemic immune surveillance are less sensitive to NK-cell mediated apoptosis.

Authors:  Jurjen H L Velthuis; Miranda Stitzinger; Remco I J M Aalbers; Hans J G M de Bont; Gerard J Mulder; Peter J K Kuppen; J Fred Nagelkerke
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

5.  Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation.

Authors:  Karin Edsparr; Per H Basse; Ronald H Goldfarb; Per Albertsson
Journal:  Cancer Microenviron       Date:  2010-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.